Modulation of Th17 Proliferation and IL-17A Gene Expression by Acetylated Form of Apigenin in Patients with Multiple Sclerosis

References

• Abbott NJ, Romero IA. 1996. Transporting therapeutics across the blood-brain barrier. Mol Med Today. 2:106–13.
   PubMedGoogle Scholar
• Almasi E, Gharagozloo M, Eskandari N, Almasi A, Sabzghabaee AM. 2017. Inhibition of apoptosis and proliferation in t cells by immunosuppressive silymarine. Iran J Allergy Asthma Immunol. 16:107–19.
   PubMed Web of Science ®Google Scholar
• Axisa -P-P, Hafler DA. 2016. Multiple sclerosis: genetics, biomarkers, treatments. Curr Opin Neurol. 29(3):345–53.
   PubMed Web of Science ®Google Scholar
• Bjartmar C, Wujek J, Trapp B. 2003. Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease. J Neurol Sci. 206(2):165–71.
   PubMed Web of Science ®Google Scholar
• Brucklacher-Waldert V, Stuerner K, Kolster M, Wolthausen J, Tolosa E. 2009. Phenotypical and functional characterization of T helper 17 cells in multiple sclerosis. Brain. 132(12):3329–41.
   PubMed Web of Science ®Google Scholar
• Grigoriadis N, Van Pesch V. 2015. A basic overview of multiple sclerosis immunopathology. Eur J Neurol. 22:3–13.
   PubMed Web of Science ®Google Scholar
• Heim KE, Tagliaferro AR, Bobilya DJ. 2002. Flavonoid antioxidants: chemistry, metabolism and structure-activity relationships. J Nutr Biochem. 13(10):572–84.
   PubMed Web of Science ®Google Scholar
• Ivanov II, Mckenzie BS, Zhou L, Tadokoro CE, Lepelley A, Lafaille JJ, Cua DJ, Littman DR. 2006. The orphan nuclear receptor RORγt directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell. 126(6):1121–33.
   PubMed Web of Science ®Google Scholar
• Jadidi-Niaragh F, Mirshafiey A. 2011. Th17 cell, the new player of neuroinflammatory process in multiple sclerosis. Scand J Immunol. 74(1):1–13.
   PubMed Web of Science ®Google Scholar
• Kang H-K, Ecklund D, Liu M, Datta SK. 2009. Apigenin, a non-mutagenic dietary flavonoid, suppresses lupus by inhibiting autoantigen presentation for expansion of autoreactive Th1 and Th17 cells. Arthritis Res Ther. 11(2):R59.
   PubMed Web of Science ®Google Scholar
• Kasiri N, Rahmati M, Eskandari N. 2018. The significant impact of apigenin on different aspects of autoimmune disease. Inflammopharmacology. 26:1359–73.
   PubMed Web of Science ®Google Scholar
• Keyhanmehr N, Motedayyen H, Eskandari N. 2019. The effects of silymarin and cyclosporine A on the proliferation and cytokine production of regulatory T cells. Immunol Invest. 1–16.
   Web of Science ®Google Scholar
• Kulkarni AP, Kellaway LA, Lahiri DK, Kotwal GJ. 2004. Neuroprotection from complement‐mediated inflammatory damage. Ann NY Acad Sci. 1035(1):147–64.
   PubMed Web of Science ®Google Scholar
• Li J, Zhang B. 2013. Apigenin protects ovalbumin-induced asthma through the regulation of Th17 cells. Fitoterapia. 91:298–304.
   PubMed Web of Science ®Google Scholar
• Liu M, Hu X, Wang Y, Peng F, Yang Y, Chen X, Lu Z, Zheng X. 2009. Effect of high‐dose methylprednisolone treatment on Th17 cells in patients with multiple sclerosis in relapse. Acta Neurol Scand. 120(4):235–41.
   PubMed Web of Science ®Google Scholar
• Lock C, Hermans G, Pedotti R, Brendolan A, Schadt E, Garren H, Langer-Gould A, Strober S, Cannella B, Allard J. 2002. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat Med. 8(5):500.
   PubMed Web of Science ®Google Scholar
• Lovett-racke AE, Yang Y, Racke MK. 2011. Th1 versus Th17: are T cell cytokines relevant in multiple sclerosis? Biochim et Biophys Acta (BBA) Mol Basis Dis. 1812(2):246–51.
   PubMed Web of Science ®Google Scholar
• Manconi M, Manca ML, Valenti D, Escribano E, Hillaireau H, Fadda AM, Fattal E. 2017. Chitosan and hyaluronan coated liposomes for pulmonary administration of curcumin. Int J Pharm. 525(1):203–10.
   PubMed Web of Science ®Google Scholar
• Matusevicius D, Kivisäkk P, He B, Kostulas N, Özenci V, Fredrikson S, Link H. 1999. Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis. Multiple Sclerosis J. 5(2):101–04.
   PubMed Web of Science ®Google Scholar
• Momčilović M, Miljković Ž, Popadić D, Marković M, Savić E, Ramić Z, Miljković D, Mostarica-stojković M. 2008. Methylprednisolone inhibits interleukin-17 and interferon-gamma expression by both naive and primed T cells. BMC Immunol. 9(1):47.
   PubMed Web of Science ®Google Scholar
• Morales Y, Parisi JE, Lucchinetti CF. 2006. The pathology of multiple sclerosis: evidence for heterogeneity. Adv Neurol. 14:27–46.
   Google Scholar
• Nicholas C, Batra S, Vargo MA, Voss OH, Gavrilin MA, Wewers MD, Guttridge DC, Grotewold E, Doseff AI. 2007. Apigenin blocks lipopolysaccharide-induced lethality in vivo and proinflammatory cytokines expression by inactivating NF-κB through the suppression of p65 phosphorylation. J Immunol. 179(10):7121–27.
   PubMed Web of Science ®Google Scholar
• Park J, Kim SH, Kim TS. 2006. Inhibition of interleukin-4 production in activated T cells via down-regulation of NF-AT DNA binding activity by apigenin, a flavonoid present in dietary plants. Immunol Lett. 103(2):108–14.
   PubMed Web of Science ®Google Scholar
• Patil RH, Babu R, Kumar MN, Kumar KK, Hegde SM, Nagesh R, Ramesh GT, Sharma SC. 2016. Anti-inflammatory effect of apigenin on LPS-induced pro-inflammatory mediators and AP-1 factors in human lung epithelial cells. Inflammation. 39(1):138–47.
   PubMed Web of Science ®Google Scholar
• Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, Fujihara K, Havrdova E, Hutchinson M, Kappos L. 2011. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 69(2):292–302.
   PubMed Web of Science ®Google Scholar
• Röhn TA, Jennings GT, Hernandez M, Grest P, Beck M, Zou Y, Kopf M, Bachmann MF. 2006. Vaccination against IL‐17 suppresses autoimmune arthritis and encephalomyelitis. Eur J Immunol. 36(11):2857–67.
   PubMed Web of Science ®Google Scholar
• Verbeek R, Plomp AC, Van Tol EA, Van Noort JM. 2004. The flavones luteolin and apigenin inhibit in vitro antigen-specific proliferation and interferon-gamma production by murine and human autoimmune T cells. Biochem Pharmacol. 68(4):621–29.
   PubMed Web of Science ®Google Scholar
• Zanin-Zhorov A, Weiss JM, Nyuydzefe MS, Chen W, Scher JU, Mo R, Depoil D, Rao N, Liu B, Wei J. 2014. Selective oral ROCK2 inhibitor down-regulates IL-21 and IL-17 secretion in human T cells via STAT3-dependent mechanism. Proc Natl Acad Sci. 111(47):16814–19.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Simpson S JR, Holloway AF, Charlesworth J, Van Der Mei I, Taylor BV. 2014. The potential role of epigenetic modifications in the heritability of multiple sclerosis. Multiple Sclerosis J. 20(2):135–40.
   PubMed Web of Science ®Google Scholar